Journal
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Volume 133, Issue -, Pages 56-63Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jpba.2016.11.009
Keywords
Amantadine; Rimantadine; Monoclonal antibody; Indirect competitive enzyme-linked immunosorbent assay; Edible chicken tissues
Categories
Funding
- Ministry of Science and Technology of the People's Republic of China [GJFP2016007, 2011-G5]
- Fundamental Research Funds for the Central Universities [2662015QC030, 2662015PY021]
Ask authors/readers for more resources
A monoclonal antibody (mAb) was produced in order to monitor the illegal use of amantadine and rimantadine in animals. The produced mAb 2G3 exhibited an IC50 value of 15.8 mu g L-1 for amantadine and exhibited cross-reactivity to both amantadine (100%) and rimantadine (70.6%). Standard curves ranged from 5 to 80 lig L-1 for 2G3. The limits of detection of the developed indirect competitive enzyme-linked immunosorbent assay (ic-ELISA) ranged from 5.0 mu g kg(-1) to 5.4 mu gkg(-1) in chicken muscle and liver. The recoveries were 81.3% to 98.1% with a coefficient of variation less than 15.7%. Good correlations were observed between the results of the ic-ELISA and liquid chromatography-mass spectrometry in the incurred tissues. These results suggest that ic-ELISA is a sensitive, accurate, and low-cost method that could be a useful tool for screening the residues of amantadine and rimantadine in chicken muscle and liver. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available